Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Gastroenterology. 2020 Aug 26;160(1):158–173.e10. doi: 10.1053/j.gastro.2020.08.041

Figure 6: Mankai supplementation during weight-loss and aFMT efficacy in mice.

Figure 6:

Experimental design (A); Mankai enrichment during weight-loss and weight change during following the weight-loss period (B); Weight regain by high fat diet+aFMT following weight-loss with added Mankai/saline gavage (C+D) Intraperitoneal glucose tolerance test (IPGTT) following the weight regain phase (week 12) (E). Weighted UniFrac distances to the weight-nadir timepoint during the weight regain phase (F).

*P ≤.05, **P ≤.01, ***P ≤.001.